Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
D2.03 - A Rare Case of Thyme Allergy in a Pediatric Patient: First Report and Clinical Insights
D2.04 - Sensitization to common food allergens in a population of portuguese children
D2.05 - A Retrospective Study Characterising the Types of Presentation of Soy Allergy in Adults
D2.06 - Peanut allergy diagnosis. Our experience
D2.08 - Post-Traumatic Stress Disorder Associated with Anaphylaxis
D2.09 - Correlation Patterns Among House Dust Mite Allergens in Allergic Rhinitis: A Molecular Sensitization Study in Mallorca
D2.10 - Can specific IgE components for egg allergy - predict egg ladder success?
D2.11 - A confidence score for basophil activation test: improving interpretation around diagnostic cutoffs
D2.12 - Indirect Basophil Activation Test: development of a user-friendly protocol for plasma and allergen testing
D2.13 - Structural Homology of Alt a 1 and Phl p 2 Suggests an explanation for coincidence of Grass and Alternaria Allergies
D2.15 - The etiology and risk factors of food allergies in children in Albania
D2.16 - Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen
D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data
D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases
D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin
D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity
D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis
D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes
D3.416 - Hereditary Alpha-Tryptasemia: A Case Series
D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download